SYDNEY, September 13, 2024 – Aurora Biosynthetics, a cutting-edge RNA therapeutics manufacturing company, has officially launched, marking a new chapter in the RNA therapeutics landscape across the Asia-Pacific region. With...

In a significant breakthrough, scientists from Trinity College Dublin have developed a promising gene therapy for treating glaucoma, a serious eye condition that affects around 80 million people globally and...

The global rise in dengue infections, estimated at around 390 million annually, continues to pose significant health challenges, especially in endemic regions. The TAK-003 dengue vaccine, developed by Takeda Vaccines,...

In a significant scientific breakthrough, a team of international researchers has unveiled a new molecule, desmethyl desamino pateamine A (DMDA-PatA), that targets specific RNA sequences to control protein synthesis at...

Acepodia, a pioneer in cell therapy development, has partnered with Pfizer through its Pfizer Ignite initiative to expand the potential of its innovative Antibody-Cell Conjugation (ACC) platform into the realm...

A groundbreaking development in cancer treatment is on the horizon, thanks to a novel bacterial nanovaccine known as LipoFM-CPG. Developed by researchers at Soochow University, this vaccine incorporates a cholesterol-modified...

Dates: 10th – 11th September 2024 Venue: Suntec Singapore Convention & Exhibition Centre As the cell and gene therapy (CGT) industry continues to evolve at a rapid pace, Asia has...

10th – 11th September 2024 | Suntec Singapore Convention & Exhibition Centre The biopharmaceutical industry has witnessed a remarkable expansion, with the global biopharma Contract Manufacturing Organization (CMO) market soaring...

Lonza, a global leader in the biopharmaceutical manufacturing industry, has secured a substantial £30 million subsidy to expand its biologics facility in the United Kingdom. This funding, provided by the...

In a strategic expansion of its manufacturing capabilities, Kyowa Kirin, a leading Japanese pharmaceutical company, has initiated the construction of a state-of-the-art biologics manufacturing facility in North Carolina, USA. This...

Researchers Push for Advanced Treatments and Vaccines for RSV Researchers from Georgia State University and the Institute for Biomedical Sciences are actively working to develop enhanced treatments and tools for...

Researchers at the Broad Institute of MIT and Harvard have made significant strides in gene-editing technology, developing a method capable of efficiently inserting or substituting entire genes within the human...

An international team of researchers has uncovered a groundbreaking discovery in the fight against antimicrobial resistance (AMR). Utilizing advanced machine learning techniques, the team identified an astounding 863,498 potential antimicrobial...

In a groundbreaking advancement in medical science, five children born deaf in China can now hear after receiving gene therapy in both ears. This follows the success of earlier treatments...

Researchers have developed a groundbreaking therapy that could revolutionize the treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH), a prevalent liver disease affecting millions globally. This innovative approach leverages short-acting IL-22-bispecific biologics,...

In a groundbreaking study published in Nature Communications a team of scientists has made significant progress in understanding the complex interplay between the immune system and cancer metabolism in the...

A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by...

The Pirbright Institute and The Vaccine Group (TVG) in Plymouth have embarked on a groundbreaking collaboration with the aim of transforming the landscape of African swine fever (ASF) vaccine development....

In a historic medical milestone, Kendric Cromer, a 12-year-old Black patient from the suburbs of Washington, D.C., has become the first individual to undergo a groundbreaking gene therapy treatment for...

The pharmaceutical industry is witnessing a seismic shift in drug delivery methods, with prefilled syringes (PFS) emerging as a frontrunner in meeting the demands of patients and healthcare providers alike....

Brazil is embarking on a groundbreaking initiative aimed at making cutting-edge cell and gene therapies accessible and affordable for its citizens. Partnering with Caring Cross, a non-profit organization specializing in...